A number of insiders bought Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) stock last year, which is great news for shareholders
yahoo.com
news
2022-06-02 16:01:38

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) case, it's fantastic news for shareholders.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.

See our latest analysis for Eledon Pharmaceuticals

Eledon Pharmaceuticals Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider purchase was by CFO & Principal Accounting Officer Paul Little for US$89k worth of shares, at about US$8.
